Luginbill, Daniel W.

Dr. Jane M. Love is co-vice chair of the firm's Intellectual Property Department, and a former member of the firm's Executive Committee. Dr. Love is a registered patent attorney with a practice focused in three main areas:

1. representation of clients before the US Patent and Trademark Office including patent preparation and prosecution, strategic patent portfolio management, patentability assessments, freedom-to-operate assessments, and patent interferences;
   
2. IP litigation related to patents in the pharmaceutical and life sciences areas, and
   
3. strategic IP advice related to corporate transactions including due diligence, and competitive landscape analysis.

Practice

Patent Advice: Dr. Love advises her clients on how to create and shape an intellectual property portfolio to protect valuable ideas and discoveries. Dr. Love prepares and prosecutes patent applications and manages large portfolios of patents in the US and globally. Dr. Love serves clients in the life sciences areas, especially in the fields of biotechnology, molecular biology, biology, biochemistry, immunology, nanotechnology and chemistry. Dr. Love has been entrusted with obtaining IP protection on significant innovations such as gene and protein therapeutics, molecular diagnostics, vaccines, treatment methods, pharmaceutical compounds, and formulations. Dr. Love is experienced in providing strategic patent advice to large and small companies, biotech and pharmaceutical start-up companies, universities and research institutions.

IP Litigation: Dr. Love utilizes the experience she has in core IP areas to represent clients in IP litigation related to life sciences patents. In particular, Dr. Love has litigation experience in the areas of antibody technology, Hatch-Waxman litigation related to pharmaceutical molecules, and synthetic peptide therapeutics.

IP Advice in Transactions: Dr. Love provides advice to large and small companies, as well as to potential investors, with regard to intellectual property that may form the basis of value in technology-related transactions. Dr. Love has experience in IP due diligence, invalidity and non-infringement opinions, patentability assessments, freedom-to-operate analyses, competitive landscape analyses and overall patent strategy.

Patent Interferences: Dr. Love is one of the few patent practitioners with significant experience in the difficult area of patent interference practice before the Board of Patent Appeals and Interferences. In addition, her practice includes representation in other contentious proceedings such as reexaminations at the USPTO, and advice as co-counsel with European agents in Opposition proceedings.

Professional Activities

Prior to practicing law, Dr. Love conducted doctoral research at the University of Pennsylvania and Thomas Jefferson Medical School in Philadelphia, PA, and post-doctoral research at Cornell University Weill Medical College in New York City in molecular biology, pharmacology and cell and developmental biology. Dr. Love was a Captain in the U.S. Army Reserve Medical Service Corp from 1991 to 1997.

Dr. Love is a member of The American and New York Bar Associations, the American Intellectual Property Law Association (AIPLA), the Licensing Executives Society (LES), the Association for University Technology Managers (AUTM), the American Association for the Advancement of Science (AAAS), the American Cancer Society (ACS), the New York Intellectual Property Law Association (NYIPLA) and the Society for Women in Science (SWIS).

Honors and Awards

Dr. Love was named a "New York Super Lawyer" in intellectual property in the 2009, 2010 and 2011 issues of Law and Politics.

In 2008, Dr. Love was named to IP Law & Business' exclusive list of the "Top 50 Under 45".

Dr. Love was recognized for her exceptional standing in the legal community in the area of intellectual property by Chambers USA: America's Leading Lawyers for Business 2005.

Speaking Engagements

Dr. Love most recently was a panelist at the April 2011 19th Annual Conference Intellectual Property Law & Policy for Fordham Intellectual Property Law Institute in New York, speaking about the Myriad case and gene patents. In January 2010, she spoke for the IP Due Diligence Conference in New York on biotech and pharma transactions by the American Conference Institute. In May 2009, she spoke at the Emerging Growth Markets Conference by Sanford C. Bernstein & Co., LLC in New York City about "Legal Perspectives in the Acquisition of Intellectual Property Rights in Emerging Markets." In June 2008, she was a panelist at "Pathways To Leadership: Keys to Success For Women In The Law," an event held by the New York City Bar Association. In October 2004, Dr. Love spoke about "Extracting Value from Intellectual Property" for the Silicon Alley Entrepreneur's Club (SAEC).

Publications & News

• Mentioned in the June 14, 2010 article "Local Law Firm Helps African Farmers," which appeared in Massachusetts Lawyers Weekly
• "Think Like a Client," New York Law Journal (June 7th 2010)
• Quoted in the January 15, 2010 article "Experts Predict Top Life Sciences Issues in 2010," which appeared in the Bureau of National Affairs' Life Sciences Law & Industry Report.
• "Life Sciences Patent Restrictions Depend on Meaning of Word 'And,' Life Sciences Law and Industry Report, Vol. 3, No. 9 (May 8, 2009).
• "In re Kubin Decision Raises Troubling Issues for Life Sciences," Life Sciences Law and Industry Report, Vol. 3, No. 8 (April 24, 2009).
• "Reach-Through Rights and the Patentability, Enforcement, and Licensing of Patents on Drug Discovery Tools," Hastings Science & Technology Law Journal, Vol. 1, No. 1, with Alfred Server and Nader Mousavi (Winter 2009).
• "The ISSCR Guidelines for Human Embryonic Stem Cell Research," Science, Volume 315 (February 2, 2007).
• "Seeking Approval of Follow-on Protein Products: A Perspective From the United States," Bio-Science Law Review (2005/2006).
• "Coming of Age - What is next for biologics as patents expire?," New York Law Journal (April 10, 2006).
• "Advanced Claim Drafting and Amendment Writing," Practicing Law Institute, Chemical Inventions Patent Prosecution Workshop (1999).